-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TokNiRNvwg0ceMmw7YkjaL23rfPz7NJIfr+8FeVNzmlUHAUgXitcLVv6p49OmOQD Z9lIWvZLQZJRLDrGev0sBQ== 0000875320-04-000085.txt : 20040727 0000875320-04-000085.hdr.sgml : 20040727 20040726105440 ACCESSION NUMBER: 0000875320-04-000085 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040723 FILED AS OF DATE: 20040726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emmens Matthew CENTRAL INDEX KEY: 0001298332 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 04930186 BUSINESS ADDRESS: BUSINESS PHONE: 617-444-6176 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2004-07-23 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001298332 Emmens Matthew C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option 9.16 2004-10-23 2014-07-22 Common Stock 20000 D Right to buy under 1996 Stock and Option Plan vesting in 16 equal quarterly installments from 7/23/2004. Valerie L. Andrews, Attorney-In-Fact 2004-07-26 EX-24 2 attach_1.htm 



CONFIRMING STATEMENT

of Signature Authority







 This Statement confirms that the undersigned has authorized and designated Kenneth S. Boger, Valerie L. Andrews, Michelle O. Rosen, Jeffrey Donohue and Anne L. Bruno, and each of them acting alone, to execute and file on behalf of the undersigned any and all Forms 3, 4 and 5 (including any amendments thereto) that the undersigned may be required to file with the United States Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Vertex Pharmaceuticals Incorporated. The authority of Kenneth S. Boger, Valerie L. Andrews, Michelle O. Rosen, Jeffrey Donohue and Anne L. Bruno under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4 or 5 with regard to the undersigned's ownership of or transactions in securities of Vertex Pharmaceuticals Incorporated, unless earlier revoked in writing. The undersigned acknowledges that Kenneth S. Boger, Valerie L. Andrews, Michelle O. Rosen, Jeffrey Donohue and Anne L. Bruno are 
not assuming, nor is Vertex Pharmaceuticals Incorporated assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Act of 1934.



This Statement supersedes and replaces any earlier dated Statement that the undersigned has executed.





 By:  /s/ Matthew Emmens





 Date:  July 20, 2004
-----END PRIVACY-ENHANCED MESSAGE-----